Literature DB >> 7225580

[Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].

R Hesse, W Tritschler, G Castelfranchi, W Bablok.   

Abstract

A new kinetic assay for antithrombin III (heparin-cofactor) in plasma was used to determine reference values. Ranges of 10--15 IU/ml at 25 degrees C and 20--29 IU/ml at 37 degrees C were found for a reference population of 219 men and 204 women 15--93 years of age. There was no evidence that these values vary with age or sex, nor was there any difference between pre- and postprandial antithrombin activities, or between smokers' and non-smokers' values. None of the illnesses present in the reference population nor any related drug therapy affected the antithrombin III level, and there was no statistically significant difference between the values for women taking oral contraceptives and those who did not. However, this latter observation does not preclude the possibility of individual variation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225580     DOI: 10.1007/bf00996752

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  8 in total

1.  [Surveillance of women taking oral contraceptives by determination of antithrombin III].

Authors:  M O Benoit; D Raichvarg; H Caillens; C Neau
Journal:  Nouv Presse Med       Date:  1979-02-10

2.  Inactivation of antithrombin 3 by fatty acids.

Authors:  N Heimburger
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-12

3.  Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.

Authors:  E D Gomperts; M Zucker; M Feesey; D Russel; D Salant; B I Joffe; D Mendelsohn; H Seftel
Journal:  J Lab Clin Med       Date:  1977-09

4.  Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.

Authors:  E Von Kaulla; W Droegemueller; N Aoki; K N Von Kaulla
Journal:  Am J Obstet Gynecol       Date:  1971-03-15       Impact factor: 8.661

5.  Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.

Authors:  P W Howie; A C Mallinson; C R Prentice; C H Horne; G P McNicol
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

6.  Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.

Authors:  M K Fagerhol; U Abildgaard
Journal:  Scand J Haematol       Date:  1970

7.  [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].

Authors:  K Lechner; E Hartmann; W H Schneider; J Spona; K Matt
Journal:  Klin Wochenschr       Date:  1976-05-01

8.  Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex.

Authors:  O R Odegärd; M K Fagerhol; M Lie
Journal:  Scand J Haematol       Date:  1976-10
  8 in total
  4 in total

1.  Hormone replacement therapy and its influence on AT-III activity in climacteric women.

Authors:  H Enzelsberger; G Heytmanek; C Kurz; M Metka
Journal:  Klin Wochenschr       Date:  1991-03-18

2.  [Predictor function of hemorheologic parameters with reference to the incidence of manifest circulatory disorders: Concept of the Aachen study].

Authors:  H Kiesewetter; F Jung; K H Ladwig; E Waterloh; P Roebruck; R Schneider; G Kotitschke; R Bach
Journal:  Klin Wochenschr       Date:  1986-07-15

3.  Antithrombin III deficiency in ischaemic stroke.

Authors:  V Hossmann; W D Heiss; H Bewermeyer
Journal:  Klin Wochenschr       Date:  1983-06-15

4.  Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

Authors:  A L Jones; T J Powles; J G Treleaven; J F Burman; M C Nicolson; H I Chung; S E Ashley
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.